UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person:
Four Partners
c/o Thomas J. Tisch
667 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
8/5/98
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7/23/97
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
1,720,200
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls,
warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
Explanation of Responses:
This amended Form 3 is being filed jointly by Four Partners
("FP"), a New York general partnership, and Four-Fourteen Partners LLC
("4-14P"), a Delaware limited liability company. The Form 3 was
originally filed by FP and is being amended to add 4-14P as a joint
filer. Information reported herein with respect to beneficial ownership
of securities by FP is current as of the filing of the amended Form 3.
The sole partners of FP are Andrew H. Tisch 1991 Trust, for which
Andrew H. Tisch is the managing trustee, Daniel R. Tisch 1991 Trust,
for which Daniel R. Tisch is the managing trustee, James S. Tisch 1991
Trust, for which James S. Tisch is the managing trustee, and Thomas J.
Tisch 1991 Trust, for which Thomas J. Tisch is the managing trustee.
Thomas J. Tisch has been appointed the Manager of FP. Andrew H. Tisch,
Daniel R. Tisch, James S. Tisch and Thomas J. Tisch are referred to
herein as the "Messrs. Tisch."
The members of 4-14P are trusts for the benefit of the offspring
of the Messrs. Tisch, partnerships the partners of which are such
trusts and partnerships the partners of which are such partnerships.
The Messrs. Tisch serve as the trustees of such trusts. Thomas J. Tisch
has been appointed the Manager of 4-14P.
The filing of this statement is not an admission by any Reporting
Person that such Reporting Person and any other person or persons
constitute a "group" for purposes of Section 13(d)(3) of the Securities
Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that any
Reporting Person is the beneficial owner of any securities owned by any
other person.
FOUR PARTNERS
By: /s/Thomas J. Tisch
Thomas J. Tisch
Manager
Date: September 4, 1998
<PAGE>
Attachment To Form 3 of Four Partners
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 8/5/98
This amended Form 3 is being filed jointly by Four Partners ("FP"), a
New York general partnership, and Four-Fourteen Partners LLC ("4-14P"), a
Delaware limited liability company.
Joint Filer Information
1. Name and Address of Reporting Person:
Four-Fourteen Partners LLC
c/o Thomas J. Tisch
667 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
8/5/98
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7/23/97
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
47,700
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls,
warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
FOUR-FOURTEEN PARTNERS LLC
By: /s/Thomas J. Tisch
Thomas J. Tisch
Manager
Date: September 4, 1998
